Surgical resection for small hepatocellular carcinoma in cirrhosis: The eastern experience

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 69-84

  Kishi, Yoji ^b   Hasegawa, Kiyoshi ^a   Kokudo, Norihiro ^a  

^a University of Tokyo   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; GADOXETIC ACID; IODINATED POPPYSEED OIL; PERFLUBUTANE; SHU 508;

ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; EARLY CANCER; ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER METASTASIS; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TISSUE SPECIFICITY; TREATMENT PLANNING;

CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; HEPATECTOMY; HUMANS; LAPAROSCOPY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MASS SCREENING;

EID: 84868317369     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_5     Document Type: Article

References (90)

1. Sanyal A, Poklepovic A, Moyneur E, Barghout V (2010) Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 26(9):2183-2191
2. Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, Yamaoka Y (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38(1):37-51 (Pubitemid 350182575)
3. Japan LCSGo (2003) General rules for the clinical and pathological study of primary liver cancer. Kenehara, Tokyo
4. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20(6):1527-1536 (Pubitemid 34260532)
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421-430 (Pubitemid 32844200)
6. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236 (Pubitemid 43112690)
7. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama N et al (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 60(4):810-819 (Pubitemid 17131919)
8. Nakashima O, Sugihara S, Kage M, Kojiro M (1995) Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 22(1):101-105
9. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28(5):1241-1246 (Pubitemid 28493833)
10. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336(8724):1150-1153 (Pubitemid 20362906)
11. (1995) Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22(3):983-993
12. Kondo F, Kondo Y, Nagato Y, Tomizawa M, Wada K (1994) Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. J Gastroenterol Hepatol 9(6):604-612 (Pubitemid 24364612)
13. Tomizawa M, Kondo F, Kondo Y (1995) Growth patterns and interstitial invasion of small hepatocellular carcinoma. Pathol Int 45(5):352-358
14. Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K (1997) Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 17(1):41-46 (Pubitemid 27092781)
15. Frachon S, Gouysse G, Dumortier J, Couvelard A, Nejjari M, Mion F, Berger F, Paliard P, Boillot O, Scoazec JY (2001) Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol 34(6):850-857 (Pubitemid 32595184)
16. Hytiroglou P (2004) Morphological changes of early human hepatocarcinogenesis. Semin Liver Dis 24(1):65-75 (Pubitemid 38496049)
17. Wang XY, Degos F, Dubois S, Tessiore S, Allegretta M, Guttmann RD, Jothy S, Belghiti J, Bedossa P, Paradis V (2006) Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 37(11):1435-1441 (Pubitemid 44739946)
18. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA, Ellis LM, Vauthey JN (2002) Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6(2):224-232 discussion 232 (Pubitemid 40433575)
19. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK (2005) Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11(9):1086-1092 (Pubitemid 41341758)
20. Matsuda Y, Yabuuchi I (1986) Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 161(3):701-705 (Pubitemid 17200421)
21. Kudo M, Tomita S, Tochio H, Mimura J, Okabe Y, Kashida H, Hirasa M, Ibuki Y, Todo A (1992) Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR Am J Roentgenol 158(1):65-74
22. Fritzsch T, Hilmann J, Kampfe M, Muller N, Schobel C, Siegert J (1990) SHU 508, a transpulmonary echocontrast agent: initial experience. Invest Radiol 25(Suppl 1):S160-S161 (Pubitemid 20276091)
23. Marelli C (1999) Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection. Eur Radiol 9(Suppl 3):S343-S346
24. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K (2008) Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 51(Suppl 1):61-69 (Pubitemid 351821844)
25. Kudo M, Hatanaka K, Inoue T, Maekawa K (2010) Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma. Oncology 78(Suppl 1):60-67
26. Fan ZH, Chen MH, Dai Y, Wang YB, Yan K, Wu W, Yang W, Yin SS (2006) Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am J Roentgenol 186(6):1512-1519 (Pubitemid 46112512)
27. Liu GJ, Xu HX, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY (2007) Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 80(953):321-330
28. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195(3):785-792
29. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J (2010) Detection and characterization offocal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 45(3):133-141
30. Kawada N, Ohkawa K, Tanaka S, Matsunaga T, Uehara H, Ioka T, Takano Y, Takakura R, Imanaka K, Tamai C, Kawaguchi T, Tomita Y, Nakanishi K, Katayama K (2010) Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography. Hepatol Res 40(9):930-936
31. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154(1):19-24 (Pubitemid 15196277)
32. Prando A, Wallace S, Bernardino ME, Lindell MM Jr (1979) Computed tomographic arteriography of the liver. Radiology 130(3):697-701 (Pubitemid 9100185)
33. Zhang K, Kokudo N, Hasegawa K, Arita J, Tang W, Aoki T, Imamura H, Sano K, Sugawara Y, Makuuchi M (2007) Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma. Arch Surg 142(12):1170-1175 discussion 1176 (Pubitemid 350294269)
34. Nanashima A, Tobinaga S, Abo T, Kunizaki M, Takeshita H, Hidaka S, Taura N, Ichikawa T, Sawai T, Nakao K, Nagayasu T (2011) Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: a preliminary study. J Surg Oncol 103(2):152-157
35. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693-699 (Pubitemid 26079803)
36. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3):373-382 (Pubitemid 34183888)
37. Nakashima T, Kojiro M (1986) Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 6(3):259-266 (Pubitemid 17203554)
38. Nathan H, Schulick RD, Choti MA, Pawlik TM (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249(5):799-805
39. Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161(4):346-350 (Pubitemid 16223044)
40. Shindoh J, Mise Y, Satou S, Sugawara Y, Kokudo N (2010) The intersegmental plane of the liver is not always flat-tricks for anatomical liver resection. Ann Surg 251(5):917-922
41. Mazziotti A, Maeda A, Ercolani G, Cescon M, Grazi GL, Pierangeli F (2000) Isolated resection of segment 8 for liver tumors: a new approach for anatomical segmentectomy. Arch Surg 135(10):1224-1229
42. Hu JX, Dai WD, Miao XY, Zhong DW, Huang SF, Wen Y, Xiong SZ (2009) Anatomic resection of segment VIII of liver for hepatocellular carcinoma in cirrhotic patients based on an intrahepatic Glissonian approach. Surgery 146(5):854-860
43. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242(2):252-259 (Pubitemid 41033442)
44. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S (1999) Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 86(8):1032-1038 (Pubitemid 29387069)
45. Yamamoto M, Takasaki K, Ohtsubo T, Katsuragawa H, Fukuda C, Katagiri S (2001) Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. Surgery 130(3):443-448 (Pubitemid 32868456)
46. Regimbeau J, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131(3):311-317 (Pubitemid 34229784)
47. Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y (2006) Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 139(3):385-394
48. Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, Tsujita E, Kuroda Y, Maehara Y (2007) Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 205(1):19-26 (Pubitemid 47016949)
49. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, Hatakeyama K (2007) Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 14(4):1356-1365 (Pubitemid 46536830)
50. Ueno S, Kubo F, Sakoda M, Hiwatashi K, Tateno T, Mataki Y, Maemura K, Shinchi H, Natsugoe S, Aikou T (2008) Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg 15(5):493-500
51. Tanaka K, Shimada H, Matsumoto C, Matsuo K, Nagano Y, Endo I, Togo S (2008) Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 143(5):607-615 (Pubitemid 351626114)
52. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, Ikai I, Kudo M, Kojiro M, Makuuchi M, Monden M, Matsuyama Y, Nakanuma Y, Takayasu K (2008) Comparison of the outcomes betweenan anatomical subsegmentectomy and a non-anatomical minor hepatectomyfor single hepatocellular carcinomas basedona Japanese nationwide survey. Surgery 143(4):469-475 (Pubitemid 351406380)
53. Kang CM, Choi GH, Kim DH, Choi SB, Kim KS, Choi JS, Lee WJ (2010) Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function. J Surg Res 160(1):81-89
54. Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Matsushita M, Todo S (2010) The impact of anatomical resection for hepatocellular carcinoma that meets the Milan criteria. J Surg Oncol 101(1):54-60
55. Dahiya D, Wu TJ, Lee CF, Chan KM, Lee WC, Chen MF (2010) Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 147(5):676-685
56. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105(2):488-494 (Pubitemid 23213535)
57. Masutani S, Sasaki Y, Imaoka S, Iwamoto S, Ohashi I, Kameyama M, Kabuto T, Ishikawa O, Furukawa H, Koyama H et al (1994) The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg 129(10):1025-1030 (Pubitemid 24320795)
58. Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P'Eng FK (1997) Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol 66(2):122-126
59. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P (1998) Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 82(6):1028-1036 (Pubitemid 28136514)
60. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101(4):796-802 (Pubitemid 39030937)
61. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245(1):36-43 (Pubitemid 46035433)
62. Shimada K, Sakamoto Y, Esaki M, Kosuge T (2008) Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. Am J Surg 195(6):775-781 (Pubitemid 351749464)
63. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K (1991) Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 14(5):802-805
64. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY(1992) Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 16(6):1367-1371
65. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106(3):720-727 (Pubitemid 24064340)
66. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108(3):768-775
67. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, Yagura K, Ohyama T, Nishio K, Ohashi K, Sho M, Yamada T, Nakano H (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg 224(5):591-595 (Pubitemid 26384881)
68. Poon RT, Fan ST, Ng IO, Wong J (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 231(4):544-551 (Pubitemid 30185862)
69. Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y (2002) Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89(1):57-62 (Pubitemid 34031308)
70. Matsui Y, Terakawa N, Satoi S, Kaibori M, Kitade H, Takai S, Kwon AH, Kamiyama Y (2007) Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection. Arch Surg 142(7):596-602 (discussion 603) (Pubitemid 47080436)
71. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K (1984) Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199(1):51-56 (Pubitemid 14218874)
72. Torzilli G, Donadon M, Montorsi M (2007) The surgical margin in liver resection for hepatocellular carcinoma: a real problem or not? Ann Surg 246 (4):690-691 (author reply 691-692) (Pubitemid 47480628)
73. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89(3):500-507 (Pubitemid 30640096)
74. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202(2):275-283 (Pubitemid 43112487)
75. Oikawa T, Ojima H, Yamasaki S, Takayama T, Hirohashi S, Sakamoto M (2005) Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol 42(2):225-229 (Pubitemid 40143469)
76. Matsuda M, Fujii H, Kono H, Matsumoto Y (2001) Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 8(4):353-359 (Pubitemid 33690560)
77. Tajima T, Yoshimitsu K, Irie H, Aibe H, Shinozaki K, Nishie A, Honda H, Shimada M (2005) Detecting postsurgical recurrent hepatocellular carcinoma with multiphasic helical computed tomography: intrahepatic metastasis or multicentric occurrence? J Comput Assist Tomogr 29(1):42-50 (Pubitemid 40194437)
78. Sakamoto M, Hirohashi S, Tsuda H, Shimosato Y, Makuuchi M, Hosoda Y (1989) Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J surg pathol 13(12):1064-1067 (Pubitemid 20010992)
79. Kawai S, Imazeki F, Yokosuka O, Ohto M, Shiina S, Kato N, Omata M (1995) Clonality in hepatocellular carcinoma: analysis of methylation pattern of polymorphic X-chromosome-linked phosphoglycerate kinase gene in females. Hepatology 22(1):112-117
80. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH (2000) Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119(2):431-440
81. Li Q, Wang J, Juzi JT, Sun Y, Zheng H, Cui Y, Li H, Hao X (2008) Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg 12(9):1540-1547. doi:10.1007/s11605-008-0591-y
82. Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS (2009) The international position on laparoscopic liver surgery: the Louisville Statement 2008. Ann Surg 250(5):825-830
83. Laurent A, Cherqui D, Lesurtel M, Brunetti F, Tayar C, Fagniez PL (2003) Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. Arch Surg 138(7):763-769 (discussion 769) (Pubitemid 36858156)
84. O'Rourke N, Fielding G (2004) Laparoscopic right hepatectomy: surgical technique. J Gastrointest Surg 8(2):213-216 (Pubitemid 38224262)
85. Belli G, Fantini C, D'Agostino A, Cioffi L, Langella S, Russolillo N, Belli A (2007) Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results. Surg Endosc 21(11):2004-2011 (Pubitemid 47620293)
86. Kaneko H, Tsuchiya M, Otsuka Y, Yajima S, Minagawa T, Watanabe M, Tamura A (2009) Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients. J Hepatobiliary Pancreat Surg 16(4):433-438
87. Haga Y, Ikei S, Ogawa M (1999) Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today 29(3):219-225 (Pubitemid 29119837)
88. Haga Y, Ikei S, Wada Y, Takeuchi H, Sameshima H, Kimura O, Furuya T (2001) Evaluation of an Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system to predict postoperative risk: a multicenter prospective study. Surg Today 31(7):569-574 (Pubitemid 32695780)
89. Evidence-GftetGf, Cancer. BCPftToL (2009) Clinical practice guidelines for hepatocellular carcinoma. Kanehara & Co., Tokyo
90. (2006) Liver (Including Intrahepatic Bile Ducts). In: Greene FL, Compton CC, Fritz AG, Shah JP, Winchester DP (ed) AJCC Cancer Staging Atlased. Springer, pp 127-132